沙库巴曲缬沙坦具有抗纤维化作用吗？ - Suppr

Is Sacubitril/Valsartan Antifibrotic?

作者信息

Zannad Faiez, Ferreira João Pedro

机构信息

Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

出版信息

J Am Coll Cardiol. 2019 Feb 26;73(7):807-809. doi: 10.1016/j.jacc.2018.11.041.

DOI:10.1016/j.jacc.2018.11.041

PMID:30784674

Abstract

摘要

相似文献

Is Sacubitril/Valsartan Antifibrotic?

J Am Coll Cardiol. 2019 Feb 26;73(7):807-809. doi: 10.1016/j.jacc.2018.11.041.

Sacubitril/Valsartan as Antifibrotic Drug: Rejuvenating the Fibrosed HFpEF Heart.

J Am Coll Cardiol. 2020 Aug 4;76(5):515-517. doi: 10.1016/j.jacc.2020.06.016.

Sacubitril/Valsartan, Cardiac Fibrosis, and Remodeling in Heart Failure.

J Am Coll Cardiol. 2019 Jun 18;73(23):3038-3039. doi: 10.1016/j.jacc.2019.03.510.

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF.

J Am Coll Cardiol. 2019 Feb 26;73(7):795-806. doi: 10.1016/j.jacc.2018.11.042.

No Aldosterone Breakthrough With the Neprilysin Inhibitor Sacubitril.

J Am Coll Cardiol. 2019 Jun 18;73(23):3037-3038. doi: 10.1016/j.jacc.2019.03.508.

Interaction Between Sacubitril and Valsartan in Preventing Heart Failure Induced by Aortic Valve Insufficiency in Rats.

J Card Fail. 2019 Nov;25(11):921-931. doi: 10.1016/j.cardfail.2019.09.008. Epub 2019 Sep 17.

Synergy between sacubitril and valsartan leads to hemodynamic, antifibrotic, and exercise tolerance benefits in rats with preexisting heart failure.

Am J Physiol Heart Circ Physiol. 2019 Feb 1;316(2):H289-H297. doi: 10.1152/ajpheart.00579.2018. Epub 2018 Nov 21.

Sacubitril/valsartan and low blood pressure in heart failure with reduced ejection fraction.

Eur Heart J. 2017 Apr 14;38(15):1144-1146. doi: 10.1093/eurheartj/ehx014.

Impact of Sacubitril-Valsartan on Markers of Glomerular Function.

Curr Heart Fail Rep. 2020 Aug;17(4):145-152. doi: 10.1007/s11897-020-00463-1.

Sacubitril-Valsartan, a New Opportunity for Heart Failure with Recovered Ejection Fraction?

Cardiology. 2020;145(5):283-284. doi: 10.1159/000506538. Epub 2020 Apr 14.

引用本文的文献

Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction.

BMC Cardiovasc Disord. 2022 May 13;22(1):217. doi: 10.1186/s12872-022-02647-0.

Cardiac Fibrosis and Fibroblasts.

Cells. 2021 Jul 6;10(7):1716. doi: 10.3390/cells10071716.

Angiotensin Receptor-Neprilysin Inhibition Attenuates Right Ventricular Remodeling in Pulmonary Hypertension.

J Am Heart Assoc. 2020 Jul 7;9(13):e015708. doi: 10.1161/JAHA.119.015708. Epub 2020 Jun 18.

Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension.

Am J Physiol Renal Physiol. 2020 Jul 1;319(1):F63-F75. doi: 10.1152/ajprenal.00125.2020. Epub 2020 May 28.

Silibinin Augments the Antifibrotic Effect of Valsartan Through Inactivation of TGF-β1 Signaling in Kidney.

Drug Des Devel Ther. 2020 Feb 13;14:603-611. doi: 10.2147/DDDT.S224308. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Is Sacubitril/Valsartan Antifibrotic?

作者信息

Zannad Faiez, Ferreira João Pedro

机构信息

Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.